1
Your Cart
1
Your Cart
Invitation Only · 2026

OPX
The Private Catalogue

A closed catalogue of research-grade peptides. Admitted by invitation. Every account reviewed by hand.

Three stages from synthesis to signature.

Each OPX product passes through a controlled pipeline — built around the principle that research integrity begins at the vial.

— 01

Solid-phase synthesis

Sequences are assembled amino-acid by amino-acid under inert atmosphere using Fmoc chemistry in a GMP-aligned facility.

— 02

Verification by HPLC & MS

Each batch is independently assayed. Chromatograms and mass spectra are published to the Certificate of Analysis on every vial.

— 03

Sterile lyophilisation

Product is lyophilised in borosilicate vials, crimped and sealed under an ISO-7 laminar-flow environment.

A considered library of peptides.

The full catalogue is visible to members. A selection is shown below — each compound is offered in a single, uniform presentation: a black-labelled 10 mL borosilicate vial, numbered and certified.

  • Placeholder

    BPC-157

    Body Protection Compound — 5 mg lyophilised research peptide.

    No. 000

    BPC-157

    Body Protection Compound — 5 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      5 mg
    • CAS No.
      137525-51-0
    • Molecular Weight
      1419.53 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    TB-500

    Thymosin Beta-4 fragment — 5 mg lyophilised research peptide.

    No. 000

    TB-500

    Thymosin Beta-4 fragment — 5 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      5 mg
    • CAS No.
      77591-33-4
    • Molecular Weight
      4963.44 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    IPA

    Ipamorelin — 5 mg lyophilised research peptide.

    No. 000

    IPA

    Ipamorelin — 5 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      5 mg
    • CAS No.
      170851-70-4
    • Molecular Weight
      711.85 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    CJC-1295

    CJC-1295 (No DAC) — 5 mg lyophilised research peptide.

    No. 000

    CJC-1295

    CJC-1295 (No DAC) — 5 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      5 mg
    • CAS No.
      863288-34-0
    • Molecular Weight
      3367.97 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    GHK-Cu

    Copper Tripeptide-1 — 50 mg lyophilised research peptide.

    No. 000

    GHK-Cu

    Copper Tripeptide-1 — 50 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      50 mg
    • CAS No.
      49557-75-7
    • Molecular Weight
      403.93 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    SEMAX

    Semax — 10 mg lyophilised research peptide.

    No. 000

    SEMAX

    Semax — 10 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      10 mg
    • CAS No.
      80714-61-0
    • Molecular Weight
      813.93 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    EPT

    Epithalon — 10 mg lyophilised research peptide.

    No. 000

    EPT

    Epithalon — 10 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      10 mg
    • CAS No.
      307297-39-8
    • Molecular Weight
      390.34 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    TA-1

    Thymosin Alpha-1 — 5 mg lyophilised research peptide.

    No. 000

    TA-1

    Thymosin Alpha-1 — 5 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      5 mg
    • CAS No.
      62304-98-7
    • Molecular Weight
      3108.29 g/mol
    • Presentation
      Lyophilised powder in sealed vial
  • Placeholder

    MT-II

    Melanotan II — 10 mg lyophilised research peptide.

    No. 000

    MT-II

    Melanotan II — 10 mg lyophilised research peptide.

    • Purity
      ≥98%
    • Net Weight
      10 mg
    • CAS No.
      121062-08-6
    • Molecular Weight
      1024.18 g/mol
    • Presentation
      Lyophilised powder in sealed vial

Verified at every molecular step.

OPX operates under a published quality framework. Each lot is accompanied by a digital Certificate of Analysis containing HPLC chromatograms, mass-spec confirmation, sequence identity, peptide content and water content.

≥ 99.2%Mean purity, HPLC
± 0.01 DaMass accuracy
< 0.5 E/small>

We audit our suppliers annually. OPX has cleared ours two years running without remediation.

L. JørgensenQC Lead, Copenhagen

Questions, candidly answered.

What does "research grade" mean?

Our peptides are sold exclusively for in-vitro laboratory research. They are not a medicine, are not intended for human or animal consumption, and are not intended to diagnose, treat, cure or prevent any condition.

How is purity verified?

Every batch is analysed by reverse-phase HPLC and confirmed by mass spectrometry. The resulting Certificate of Analysis is matched to the batch number printed on the vial and downloadable from your account.

How should I store OPX vials?

Unreconstituted lyophilised peptide is stored at −20 °C, protected from light. Once reconstituted with bacteriostatic water, vials should be refrigerated at 2–8 °C and used within a short research window appropriate to the compound.

Where does OPX ship?

We ship temperature-controlled parcels within the United Kingdom and European Union. Shipments leave our facility on Tuesdays and Thursdays with fully tracked next-day delivery.

How do I join OPX?

Access to OPX is by invitation. Most members arrive through referral by an existing account holder; a smaller number are admitted after a direct application and credential review. We do not operate a public checkout.

A private list. By invitation.

If you've been referred — or believe your laboratory qualifies — submit a short application and we will respond within five working days.